Back to All Events

Steven Holtzmanm, CEO of Decibel Therapeutics

  • SCTR 08-146AB Philadelphia, PA 19104 (map)

How to build a Biotech company – Strategic deal-making and Equity financing

PennHealthX is excited to host Mr. Steven Holtzman on Thursday 4/4 for our first biotech crash-course series talk this semester. (MS1s: if you recognize the last name, yes it is Bryan’s dad). Mr. Holtzman is currently the President and CEO at Decibel Therapeutics, a clinical-stage biotechnology company that focuses on developing solutions for hearing and balance disorders. www.decibeltx.com.

 

In the biotech field, he is known as a deal-maker, a reputation he developed at Millennium Pharmaceuticals. Millennium as a “phenomenon” has been well chronicled.  They did a Series A venture round at $ 1/share in late-1993.  At the height of the “genomics bubble” in 2000, that $1 share was worth $386. For those who are interested, there is a HBS case written about this (attached in this email).

 

He will be talking to us about how to build a biotech company with strategic deal-making, equity financing and corporate partnering.

Earlier Event: November 30
Gary Gottlieb, MD, MBA